AdaptHealth Corp vs Enbridge Inc — how do they compare? AdaptHealth Corp trades at $5.77 (market cap $753.09M), while Enbridge Inc trades at $51.52 (market cap $112.62B). The key difference: Enbridge Inc is far larger — about 149.5× AdaptHealth Corp's market cap, and Enbridge Inc pays a 5.34% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | ENB | |
|---|---|---|
Market Cap | $753.09M | $112.62B |
Sector | Health | Energy |
52-Week High | $13.38 | $58.04 |
52-Week Low | $5.22 | $45.23 |
Enterprise Value | $2.77B | $196.53B |
Dividend Yield | — | 5.34% |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $5.63, up 7.85% today but remains under significant pressure after recent earnings disappointments. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal negative profitability with a -6.82% net margin and three consecutive quarterly earnings misses. The company is restructuring by selling its diabetes unit to focus on sleep and respiratory care, but faces multiple securities fraud investigations following guidance revisions.
Despite 75% analyst buy ratings and an $11 consensus price target suggesting 95% upside, substantial risks exist including ongoing legal probes, execution challenges with new fixed-price contracts, and negative cash flow trends. The stock presents high-risk speculation amid operational restructuring and legal uncertainties.
ENB trades at $51.51, up 0.23% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 EPS of $0.46, beating estimates, and maintains a strong dividend history with 31 consecutive years of increases. Revenue grew to $65.19B in 2025, though net income margin is expected to dip to 7.33% in 2026. Analyst consensus is evenly split between Buy and Hold ratings.
Outlook is mixed: robust infrastructure demand and a $41B project backlog support growth, but legal challenges and volatile energy markets pose risks. The stock offers a solid yield and consistent dividend growth, appealing for income investors, yet faces headwinds from regulatory scrutiny and debt levels nearing 49% of assets.
Trailing returns across standard periods
Latest headlines on both assets
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →